메뉴 건너뛰기




Volumn 91, Issue 5, 2005, Pages 670-671

Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; IRBESARTAN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; STATINE DERIVATIVE;

EID: 17644391433     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.036509     Document Type: Article
Times cited : (11)

References (5)
  • 1
    • 0037834636 scopus 로고    scopus 로고
    • Angiotensin receptors: Distribution, signalling and function
    • Dinh D, Frauman AG, Johnston CI. Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) 2001;100:481-92.
    • (2001) Clin Sci (Lond) , vol.100 , pp. 481-492
    • Dinh, D.1    Frauman, A.G.2    Johnston, C.I.3
  • 2
    • 0035131472 scopus 로고    scopus 로고
    • Irbesartan, an AT1 receptor antagonist, reduces markers of inflammation in patients with early atherosclerosis
    • Navalkar S, Parthasarathy S, Santanam N, et al. Irbesartan, an AT1 receptor antagonist, reduces markers of inflammation in patients with early atherosclerosis. J Am Coll Cardiol 2001;37:440-4.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 440-444
    • Navalkar, S.1    Parthasarathy, S.2    Santanam, N.3
  • 3
    • 0035890275 scopus 로고    scopus 로고
    • Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease
    • Khan BV, Navalkar S, Khan QA, et al. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J Am Coll Cardiol 2001;38:1662-7.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1662-1667
    • Khan, B.V.1    Navalkar, S.2    Khan, Q.A.3
  • 4
    • 0344942643 scopus 로고    scopus 로고
    • Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease
    • Lauten WB, Khan QA, Rajagopalan S, et al. Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease. J Am Coll Cardiol 2003;91:1116-9.
    • (2003) J Am Coll Cardiol , vol.91 , pp. 1116-1119
    • Lauten, W.B.1    Khan, Q.A.2    Rajagopalan, S.3
  • 5
    • 0035826792 scopus 로고    scopus 로고
    • Enhanced response of blood monocytes to in vitro lipopolysaccharide challenge in patients with recurrent unstable angina
    • Liuzzo G, Angiolillo DJ, Buffon A. Enhanced response of blood monocytes to in vitro lipopolysaccharide challenge in patients with recurrent unstable angina. Circulation 2001;103(18):2236-41.
    • (2001) Circulation , vol.103 , Issue.18 , pp. 2236-2241
    • Liuzzo, G.1    Angiolillo, D.J.2    Buffon, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.